ENDOCYTE INC 4
4 · ENDOCYTE INC · Filed Nov 7, 2014
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Ellis P Ron
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2014-11-05$1.91/sh+19,060$36,405→ 225,965 total - Exercise/Conversion
Stock Option (right to buy)
2014-11-05−19,060→ 0 totalExercise: $1.91Exp: 2016-08-31→ Common Stock (19,060 underlying)
Footnotes (2)
- [F1]Includes 2319 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on June 15, 2014.
- [F2]The option is fully vested and immediately exercisable.